This post is also available in:
עברית (Hebrew)
Chronic wounds remain one of the more difficult problems in regenerative medicine. In many cases, the body fails to maintain the immune and signaling activity needed for proper tissue repair, causing wounds to remain open for long periods. Existing treatments often rely on applying healing proteins externally, but those molecules degrade quickly and do not stay concentrated at the wound site long enough to sustain recovery.
Researchers have now developed a “living bandage” designed to solve that problem by continuously producing therapeutic proteins directly inside the wound itself. Instead of delivering a one-time dose of medication, the system uses engineered living cells embedded inside a protective material to act as miniature biological factories.
The patch contains ARPE-19 cells genetically modified to secrete cytokines, signaling proteins that regulate inflammation, immune activity, and tissue regeneration. The engineered cells are enclosed within a biocompatible hydrogel matrix that allows nutrients and therapeutic proteins to move through while shielding the cells from immune rejection by the body.
According to Interesting Engineering, the researchers focused on cytokines including IL-10, IL-12, and TGF-β, which play important roles in coordinating wound healing processes. By continuously releasing these proteins over time instead of in short bursts, the patch creates a more stable biochemical environment around damaged tissue.
In preclinical testing on wound models in mice and pigs, the system accelerated tissue repair compared to conventional approaches. Researchers also analyzed how the patch affected cellular activity using RNA sequencing and transcriptomic analysis. The results showed increased activation of genes associated with immune regulation and tissue regeneration, helping explain the faster healing response observed during testing.
One of the more flexible aspects of the platform is its modular design. Because the therapeutic cells can be reprogrammed, researchers believe the same system could eventually produce different combinations of cytokines, growth factors, or other proteins depending on the medical application.
From a defense and emergency medicine perspective, technologies capable of accelerating wound healing could become valuable for treating traumatic injuries in remote or resource-limited environments where long-term recovery support is difficult to maintain.
The researchers are now exploring ways to control protein release more precisely, including systems that may eventually regulate cytokine production dynamically in real time.
The research was published here.
